Electrocardiograph (ECG) Market Size, Share, Growth, and Industry Analysis, By Type (Monitoring ECG Systems,Diagnostic ECG Systems), By Application (Home-based Users,Hospitals), Regional Insights and Forecast to 2035

Electrocardiograph (ECG) Market Overview

The global Electrocardiograph (ECG) Market is forecast to expand from USD 10893.42 million in 2026 to USD 11786.68 million in 2027, and is expected to reach USD 22136.77 million by 2035, growing at a CAGR of 8.2% over the forecast period.

The global Electrocardiograph (ECG) Market recorded over 105 million ECG procedures worldwide in 2024, demonstrating significant diagnostic reliance on these systems. Hospitals conducted approximately 75% of ECG procedures globally, showing their dominance in patient monitoring. Resting ECG systems maintained close to 50% market share in 2021, making them the most widely used product type. The mobile ECG device segment expanded substantially, valued in billions, with North America contributing over 44% to global share in 2024. Meanwhile, the 12-channel ECG system segment alone crossed 1,600 million units in demand by 2024, reflecting the critical importance of advanced diagnostics across healthcare.

The United States remains the largest market in the global ECG industry, accounting for nearly 82% of the North American share in 2023. Hospitals in the U.S. conducted over 75% of ECG procedures, underlining the dominance of institutional healthcare providers. Resting ECG systems held a share of around 46% of the U.S. ECG market in 2022, reflecting continued reliance on routine diagnostics. The U.S. performed millions of diagnostic tests annually, with high adoption of portable and wearable ECG systems. The growing aging population and cardiovascular disease incidence significantly drive domestic demand for both hospital-based and mobile ECG technologies.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Resting ECG systems contributed approximately 50% of the global ECG device market share in 2021.
• Major Market Restraint: Hospitals accounted for 75% of all ECG procedures globally, limiting adoption in home-based environments.
• Emerging Trends: North America represented 44.31% of global mobile ECG share in 2024, highlighting remote monitoring growth.
• Regional Leadership: North America held about 40% of global ECG market share in 2021.
• Competitive Landscape: The U.S. contributed nearly 82% of the North American ECG market in 2023.
• Market Segmentation: Resting ECG systems comprised 50%, and hospital usage exceeded 75% worldwide in 2024.
• Recent Development: The mobile ECG device segment was valued at over 4,100 million units in 2024.

Electrocardiograph (ECG) Market Latest Trends

Latest trends in the Electrocardiograph (ECG) Market demonstrate rapid advancements in digital health, wearable devices, and AI integration. Globally, more than 105 million ECG procedures were recorded in 2024, with hospitals conducting 75% of them. However, the growing consumer shift toward personal health devices has boosted mobile ECG system adoption. The mobile ECG device segment exceeded 4,100 million units in 2024, with North America commanding 44.31% of the global share.

Electrocardiograph (ECG) Market Dynamics

The Electrocardiograph (ECG) Market Dynamics highlight the balance between growth drivers, restraints, opportunities, and challenges shaping the global industry. Key drivers include the rising prevalence of cardiovascular diseases, with more than 105 million ECG procedures performed worldwide in 2024, and hospitals executing nearly 75% of these tests. Resting ECG systems account for 50% of global usage, supported by growing adoption of mobile ECG devices surpassing 4,100 million units. Restraints include hospital-centric dominance that slows home-based adoption. Opportunities lie in wearable technologies, with North America leading at 44.31% share in mobile ECG devices. Challenges involve device complexity, AI integration, and regulatory compliance.

DRIVER

"Growing prevalence of cardiovascular diseases and aging population"

Over 105 million ECG procedures were performed worldwide in 2024, with hospitals conducting 75% of them. The rising number of cardiovascular disease cases, combined with an expanding geriatric population, has fueled global ECG demand. Resting ECG systems retained 50% of the market, while mobile ECG devices surged to over 4,100 million units in 2024, reflecting adoption beyond traditional hospital settings. The U.S. contributed nearly 82% of North America’s market, with resting ECG systems accounting for 46% of usage. Population health trends, combined with technological innovations in portable and wearable devices, represent key drivers of sustained market growth.

RESTRAINT

"Hospital-centric procedures limit home-based adoption"

While technological innovation drives growth, adoption is restrained by hospital dependency. In 2024, hospitals executed 75% of ECG procedures globally, leaving home-based use limited. Despite mobile ECG expansion beyond 4,100 million units, barriers such as regulatory complexity, patient training needs, and reimbursement gaps slow broader adoption. Home-based monitoring still accounts for a small portion of the total ECG market. The reliance on institutional care limits scaling in community health settings, particularly in emerging markets, where home-based ECG use is underrepresented. Hospitals continue to dominate the ECG ecosystem despite opportunities in personal health monitoring.

OPPORTUNITY

"Wearable and remote monitoring expansion"

The mobile ECG market exceeded 4,100 million units in 2024, and North America held 44.31% of the share. The 12-channel ECG segment’s growth to 1,600 million units indicates rising demand for advanced diagnostic capabilities. Remote patient monitoring technologies and AI-enabled detection systems are increasing ECG adoption outside of traditional hospital settings. Smartwatch-integrated ECGs and smartphone-enabled ECG platforms are expanding access across both developed and emerging markets. Demand for outpatient services and personalized medicine presents long-term opportunities. Growing adoption of telemedicine and digital health ecosystems further supports wearable ECG system growth across all geographies.

CHALLENGE

"Device complexity and regulatory hurdles"

Electrocardiograph devices face challenges in accuracy, usability, and certification. Hospitals’ dominance with 75% of ECG procedures demonstrates reliance on clinical environments for accuracy and trust. Portable devices must overcome issues such as noise, electrode misplacement, and limited sensitivity in mobile applications. Regulatory frameworks present another barrier, as consumer-grade devices require stringent medical certifications. Complexity in integrating AI tools for automated detection adds technical hurdles. Additionally, adoption in low-resource regions is challenged by infrastructure limitations. While wearable and mobile ECG adoption expands, complexity in usage and compliance standards remain significant obstacles for widespread ECG system integration.

Electrocardiograph (ECG) Market Segmentation

The ECG market is segmented by type and application. By Type, resting ECG systems dominate with around 50% of the global market, while mobile ECG devices surpassed 4,100 million units in 2024. By Application, hospitals conducted 75% of procedures worldwide in 2024, with home-based use remaining limited. Resting ECG and diagnostic 12-channel systems exceeded 1,600 million units, showing strong demand for advanced clinical tools. Meanwhile, mobile ECG devices integrated with smartphones, smartwatches, and remote monitoring systems are expanding home-based applications. However, hospital usage continues to dominate, especially in the U.S., where resting systems accounted for 46% of adoption.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Monitoring ECG Systems: Monitoring ECG Systems form a major part of the Electrocardiograph (ECG) Market, especially with the growth of portable, wireless, and wearable devices. The mobile ECG devices segment crossed 4,100 million units in 2024, showcasing rapid adoption among patients requiring long-term monitoring outside hospitals.

The Monitoring ECG Systems segment: Projected to reach USD 4650.34 million in 2025 and climb to USD 9421.56 million by 2034, securing a significant 46.2% global market share while maintaining a CAGR of 8.5%, driven by robust adoption of wearable and mobile technologies, increasing cardiac patient load, and growing demand for continuous monitoring in both clinical and homecare environments.

Top 5 Major Dominant Countries in the Monitoring ECG Systems Segment

• United States: Expected to record USD 1825.45 million by 2025 with 39.2% share, expanding at CAGR of 8.6%; growth reflects advanced hospital infrastructure, wide acceptance of wearable ECG devices, and continuous investment in healthcare digitization supporting superior monitoring technologies across the country.
• Germany: Projected at USD 420.38 million in 2025 with 9.0% share, advancing at CAGR of 8.3%; expansion is supported by highly developed healthcare infrastructure, high cardiovascular disease incidence, and increased integration of precision monitoring systems across hospitals and specialty care facilities.
• China: Forecast to reach USD 698.52 million in 2025 with 15.0% share, advancing at CAGR of 9.0%; this reflects healthcare modernization, rising cardiac patient volumes, and significant government support for remote monitoring ECG solutions, positioning China as a global growth leader.
• Japan: Expected at USD 312.12 million in 2025 with 6.7% share, growing at CAGR of 7.8%; the rise is driven by an aging population, increased prevalence of cardiovascular diseases, and high adoption of long-term cardiac monitoring devices within advanced healthcare settings.
• India: Estimated at USD 295.10 million in 2025 with 6.3% share, showing the fastest growth at CAGR of 9.2%; expansion is led by rapid urbanization, improving healthcare access in rural areas, and growing adoption of portable ECG systems tailored for affordability and accessibility.

Diagnostic ECG Systems: Diagnostic ECG Systems remain the backbone of the global Electrocardiograph (ECG) Market. Resting ECG systems accounted for nearly 50% of the global ECG device market in 2021, highlighting their consistent use in hospital and clinic settings. Additionally, advanced 12-channel ECG systems surpassed 1,600 million units in demand by 2024, showing the importance of high-resolution diagnostics.

The Diagnostic ECG Systems segment: Valued at USD 5417.52 million in 2025 and projected to reach USD 11037.56 million by 2034, securing a commanding 53.8% market share and recording a CAGR of 7.9%. Growth is driven by widespread hospital adoption of resting ECG and 12-channel diagnostic systems, increasing cardiovascular disease incidence, and the need for advanced diagnostic accuracy across both developed and emerging healthcare markets.

Top 5 Major Dominant Countries in the Diagnostic ECG Systems Segment

• United States: Expected to record USD 2163.75 million in 2025 with 39.9% share, advancing at CAGR of 8.0%; demand is fueled by the dominance of hospitals in diagnostic ECG usage, integration of 12-channel systems, and ongoing emphasis on early cardiovascular disease detection through advanced medical technologies.
• United Kingdom: Forecast to achieve USD 368.25 million in 2025 with 6.8% share, expanding at CAGR of 7.7%; growth reflects strong demand in hospital cardiology departments, rising cardiovascular burden, and increased adoption of mobile-enabled diagnostic ECG devices within the nation’s well-established healthcare infrastructure.
• China: Projected to reach USD 740.85 million in 2025 with 13.7% share, posting CAGR of 8.6%; expansion is supported by rapid healthcare reforms, rising aging population, high prevalence of heart diseases, and accelerated investments in hospital-based diagnostic systems and outpatient cardiology clinics.
• Japan: Expected at USD 362.10 million in 2025 with 6.7% share, advancing at CAGR of 7.5%; growth is driven by advanced healthcare systems, high demand for accurate cardiac diagnostics, and rising adoption of resting and multi-channel ECG systems catering to an elderly population with complex cardiovascular needs.
• France: Estimated at USD 274.80 million in 2025 with 5.1% share, progressing at CAGR of 7.8%; demand reflects strong cardiology-focused hospital infrastructure, increasing patient admissions for cardiovascular conditions, and expanding integration of digital diagnostic ECG systems in both private and public healthcare facilities.

BY APPLICATION

Hospitals: Hospitals dominate the Electrocardiograph (ECG) Market, conducting nearly 75% of all global ECG procedures in 2024. Institutional dominance stems from the need for accurate, large-scale diagnostics and established healthcare infrastructure. Resting ECG systems accounted for 46% of the U.S. hospital-based market in 2022, showing their importance in routine care.

The Home-based Users segment: Valued at USD 2800.42 million in 2025 and projected to grow steadily with a 27.8% global market share while recording a CAGR of 8.9%. This expansion is fueled by rising adoption of wearable ECG devices, smartphone-based monitoring applications, and portable diagnostic solutions that enable patients to manage cardiovascular health outside clinical settings, reducing hospital dependency and supporting preventive care models.

Top 5 Major Dominant Countries in the Home-based Users Segment

• United States: Expected to register USD 1112.16 million in 2025 with 39.7% share, advancing at CAGR of 9.0%; growth is driven by strong consumer adoption of smartwatches with ECG features, high awareness of cardiovascular risks, and widespread telemedicine integration.
• China: Projected to reach USD 490.52 million in 2025 with 17.5% share, growing at CAGR of 9.4%; demand reflects healthcare digitization, smartphone penetration, and government-supported initiatives encouraging at-home monitoring for chronic cardiovascular conditions.
• Germany: Estimated at USD 274.84 million in 2025 with 9.8% share, advancing at CAGR of 8.6%; expansion is supported by national digital health adoption, strong elderly population base, and widespread deployment of portable ECG devices within personal healthcare programs.
• Japan: Expected at USD 218.43 million in 2025 with 7.8% share, achieving CAGR of 8.1%; growth comes from high aging population, increased demand for long-term monitoring, and integration of mobile ECG solutions within routine care and wellness technologies.
• India: Forecast to record USD 198.74 million in 2025 with 7.1% share, growing at CAGR of 9.7%; expansion is driven by rising urbanization, affordability of mobile ECG systems, and government-led digital health initiatives targeting preventive cardiac care at the household level.

Home-based Users: Home-based ECG use remains smaller compared to hospitals but is expanding rapidly. Mobile ECG devices, including wearable monitors and smartphone-enabled systems, reached over 4,100 million units in 2024. Adoption is fueled by rising consumer demand for personalized healthcare and remote monitoring. North America, with 44.31% global share in mobile ECG, is leading in home-based adoption.

The Hospitals segment: Projected at USD 7267.44 million in 2025, representing a dominant 72.2% market share, with a CAGR of 7.9% through 2034. Hospitals remain the cornerstone of the ECG market due to their advanced diagnostic capacity, reliance on resting and 12-channel ECG systems, and ability to handle a high volume of patient procedures, accounting for the majority of global ECG usage.

Top 5 Major Dominant Countries in the Hospitals Segment

• United States: Estimated at USD 2894.97 million in 2025 with 39.8% share, advancing at CAGR of 8.0%; dominance reflects advanced healthcare infrastructure, high patient volume, and continuous integration of diagnostic ECG technologies in hospitals and specialized cardiology centers.
• China: Expected to record USD 1154.85 million in 2025 with 15.9% share, progressing at CAGR of 8.3%; demand is driven by an increasing cardiovascular disease burden, strong government support for hospital expansions, and rising patient admissions for diagnostic ECG testing.
• Germany: Forecast at USD 420.34 million in 2025 with 5.8% share, expanding at CAGR of 7.7%; growth reflects well-established cardiology infrastructure, widespread hospital usage of multi-channel ECG systems, and rising need for accurate cardiovascular diagnostics.
• Japan: Projected to achieve USD 356.32 million in 2025 with 4.9% share, advancing at CAGR of 7.4%; growth is tied to an aging population, hospital-centric diagnostic demand, and rapid adoption of resting ECG systems in inpatient and outpatient departments.
• France: Expected at USD 298.72 million in 2025 with 4.1% share, advancing at CAGR of 7.6%; demand reflects strong hospital-based cardiac care services, increased patient admissions, and growing preference for advanced diagnostic ECG technologies in public and private healthcare facilities.

Regional Outlook for the Electrocardiograph (ECG) Market

Regional ECG market performance shows clear differences in adoption. North America leads with around 40% global market share and high U.S. representation (82% of North America’s total in 2023). Europe follows with strong healthcare infrastructure and demand for advanced diagnostics. Asia-Pacific is the fastest-growing region, led by China, India, and Japan. Middle East & Africa remains an emerging market, with expanding infrastructure but lower overall adoption. Regional segmentation highlights the global reliance on hospitals, with 75% of procedures performed in institutional settings, though wearable and mobile ECG growth is shifting opportunities in all regions.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America dominates the global ECG market, holding nearly 40% of global share. The U.S. accounted for approximately 82% of the North American ECG market in 2023, reflecting its size and healthcare infrastructure. In 2023, U.S. ECG equipment use exceeded 2,100 million units, with resting ECG systems contributing 46% share in 2022. Hospitals conducted 75% of ECG procedures, showing institutional dominance. Mobile ECG adoption has grown, with the segment surpassing 4,100 million units in 2024, and North America represented 44.31% of global mobile ECG share. Advanced healthcare facilities, insurance penetration, and demand for early cardiovascular detection drive regional growth.

The North America ECG Market: Valued at USD 3897.49 million in 2025, holding 38.7% global market share, and expected to grow at a CAGR of 8.1%. Expansion is supported by high prevalence of cardiovascular diseases, strong hospital infrastructure, and rapid adoption of mobile ECG devices across both hospitals and homecare, making North America the largest contributor to the global ECG market.

North America – Major Dominant Countries

• United States: Projected at USD 3288.73 million in 2025, accounting for 84.4% regional share with CAGR of 8.2%; dominance stems from advanced healthcare systems, high patient volume, and strong integration of wearable and diagnostic ECG technologies across hospitals and outpatient centers.
• Canada: Expected to record USD 348.74 million in 2025, representing 8.9% share, advancing at CAGR of 7.8%; growth reflects nationwide emphasis on preventive cardiology, rising digital health initiatives, and widespread use of ECG systems in both urban and regional hospitals.
• Mexico: Forecast to reach USD 162.38 million in 2025, capturing 4.2% share, with CAGR of 8.5%; expansion is driven by expanding healthcare coverage, rising demand for diagnostic ECG testing, and the adoption of portable ECG systems in both public and private healthcare facilities.
• Puerto Rico: Valued at USD 52.85 million in 2025, accounting for 1.4% regional share, progressing at CAGR of 7.5%; growth is supported by improved access to hospital-based cardiac diagnostics and incremental adoption of mobile ECG devices.
• Cuba: Estimated at USD 44.79 million in 2025, with 1.1% share and CAGR of 7.3%; growth reflects modernization of healthcare facilities, increasing prevalence of cardiovascular disorders, and gradual expansion of diagnostic ECG adoption in urban centers.

EUROPE

Europe represents a strong ECG market, ranking second globally. The region shows consistent adoption of diagnostic systems, supported by robust hospital infrastructure and universal healthcare coverage. Resting ECG systems accounted for nearly 50% of device usage across Europe in 2021. Mobile ECG devices are gaining popularity, though hospitals remain the largest end-users, conducting over 70% of procedures.

The Europe ECG Market: Valued at USD 2849.54 million in 2025, representing 28.3% share of the global market, and expected to grow at a CAGR of 7.8%. Europe’s strong position is supported by advanced hospital infrastructure, rising cardiovascular burden, and significant adoption of mobile ECG devices within both personal and professional healthcare systems.

Europe – Major Dominant Countries

• Germany: Expected to reach USD 620.48 million in 2025, with 21.7% share and CAGR of 7.9%; driven by strong cardiology infrastructure, a large elderly population, and widespread reliance on hospital-based diagnostic ECG devices.
• United Kingdom: Projected at USD 524.39 million in 2025, representing 18.4% share, expanding at CAGR of 7.6%; growth reflects strong adoption of both diagnostic and mobile ECG systems, high cardiovascular prevalence, and government-driven digital health initiatives.
• France: Forecast at USD 462.87 million in 2025, capturing 16.2% share with CAGR of 7.5%; expansion is tied to strong hospital-centric adoption, increased cardiac admissions, and the integration of advanced 12-channel diagnostic ECG systems.
• Italy: Expected at USD 395.24 million in 2025, accounting for 13.9% share, growing at CAGR of 7.4%; growth stems from strong diagnostic hospital infrastructure and consistent demand for ECG systems in both urban and regional healthcare facilities.
• Spain: Projected at USD 312.56 million in 2025, representing 11.0% share, with CAGR of 7.6%; supported by an increasing cardiovascular patient population, high emphasis on preventive care, and rising adoption of mobile ECG solutions in outpatient environments.

ASIA-PACIFIC

Asia-Pacific is the fastest-growing ECG region, with rising demand in India, China, and Japan. The region accounts for a significant share of global procedures, with hospitals conducting over 75% of ECGs. Rising population health risks, including diabetes and hypertension, contribute to cardiovascular disease prevalence. Demand for mobile ECG devices is accelerating, with over 30% regional growth in usage between 2022 and 2024.

The Asia ECG Market: Valued at USD 2396.68 million in 2025, accounting for 23.8% global share, advancing at a CAGR of 8.7%. Growth is fueled by expanding healthcare infrastructure, high prevalence of cardiovascular diseases, rising population, and accelerated adoption of digital health solutions, particularly in emerging economies like China and India.

Asia – Major Dominant Countries

• China: Forecast to reach USD 1391.50 million in 2025, representing 58.0% of Asia’s share, progressing at CAGR of 9.0%; expansion is driven by rapid modernization of healthcare, strong hospital expansions, and significant adoption of mobile ECG systems for remote monitoring.
• Japan: Expected at USD 680.12 million in 2025, capturing 28.4% share, with CAGR of 7.8%; growth stems from an aging population with high cardiovascular risk, reliance on hospital-based diagnostics, and widespread use of advanced 12-channel ECG systems.
• India: Projected at USD 258.73 million in 2025, representing 10.8% share, recording a strong CAGR of 9.4%; demand is boosted by healthcare infrastructure development, increasing prevalence of cardiovascular diseases, and rising penetration of affordable portable ECG systems.
• South Korea: Estimated at USD 153.64 million in 2025, covering 6.4% share, with CAGR of 8.2%; growth reflects advanced medical technology adoption, hospital-focused demand, and steady integration of AI-powered diagnostic ECG systems.
• Indonesia: Expected to record USD 94.69 million in 2025, securing 3.9% share, advancing at CAGR of 8.8%; expansion reflects strengthening healthcare facilities, growing urban population, and rising awareness of preventive cardiovascular care supported by mobile ECG solutions.

MIDDLE EAST & AFRICA

The Middle East & Africa ECG market is smaller compared to North America, Europe, and Asia-Pacific but demonstrates steady growth. Hospitals dominate with over 70% of all ECG procedures, as home-based applications remain limited. Resting ECG systems account for nearly 50% of market share across the region, while adoption of mobile ECG systems is gradually increasing.

The Middle East & Africa ECG Market: Projected at USD 924.15 million in 2025, securing 9.2% share, with an expected CAGR of 7.6%. Growth is supported by rising healthcare investments, expanding hospital infrastructure, and increasing prevalence of cardiovascular diseases, although adoption remains uneven across different sub-regions.

Middle East & Africa – Major Dominant Countries

• Saudi Arabia: Expected at USD 218.47 million in 2025, representing 23.6% share, progressing at CAGR of 7.9%; growth reflects investments in digital healthcare, expansion of cardiology departments, and hospital-based demand for advanced ECG systems.
• United Arab Emirates: Projected at USD 186.92 million in 2025, capturing 20.2% share, expanding at CAGR of 8.0%; expansion is fueled by advanced healthcare infrastructure, high adoption of hospital ECG diagnostics, and government initiatives to promote digital health technologies.
• South Africa: Estimated at USD 163.35 million in 2025, accounting for 17.6% share, advancing at CAGR of 7.5%; growth stems from increased cardiovascular admissions in public hospitals and adoption of mobile ECG devices in urban regions.
• Egypt: Forecast to achieve USD 143.26 million in 2025, covering 15.5% share, with CAGR of 7.4%; expansion reflects improvements in healthcare infrastructure, hospital expansions, and demand for diagnostic ECGs in metropolitan cities.
• Nigeria: Projected at USD 118.15 million in 2025, with 12.8% share, advancing at CAGR of 7.7%; demand reflects urban population growth, expansion of cardiology services, and gradual adoption of mobile ECG systems to improve accessibility across hospitals.
•  

List of Top Electrocardiograph (ECG) Companies

• Philips Healthcare
• GE Healthcare
• Schiller
• Nihon Kohden
• Johnson and Johnson
• Mindray Medical
• Opto Circuits
• Medtronic

GE Healthcare: Holds a significant global ECG market share exceeding 20%, with strong product presence in diagnostic and resting ECG systems.

Philips Healthcare: Accounts for over 18% of global ECG share, with leadership in portable ECG and hospital-based diagnostic solutions.

Investment Analysis and Opportunities

Investment opportunities in the ECG market are driven by digital transformation and adoption of remote monitoring. The mobile ECG segment exceeded 4,100 million units in 2024, and North America held 44.31% share, reflecting rising opportunities for connected health. Resting ECG systems continue to dominate, with nearly 50% of total usage globally, making them stable investments. Advanced 12-channel systems exceeded 1,600 million units, highlighting demand for higher-resolution diagnostics.

New Product Development

Innovation in the ECG market has centered on connectivity, portability, and diagnostic accuracy. Portable ECG systems integrated into smartwatches and smartphones have transformed accessibility, enabling consumers to track heart rhythms in real time. AI-powered ECGs now allow automatic detection of arrhythmias and pacemaker activity, reducing the burden on clinicians.

Five Recent Developments

• Launch of advanced 12-channel ECG devices exceeding 1,600 million units in 2024.
• Expansion of mobile ECG devices surpassing 4,100 million units globally in 2024.
• North America captured 44.31% of global mobile ECG share in 2024.
• Resting ECG systems maintained 50% market dominance in 2021–2024.
• S. hospitals accounted for 75% of procedures, maintaining institutional dominance by 2024.

Report Coverage of Electrocardiograph (ECG) Market

The Electrocardiograph (ECG) Market Report provides a comprehensive overview of global trends, drivers, restraints, segmentation, and regional outlook. It covers both diagnostic and monitoring systems, with detailed analysis of resting ECG, mobile ECG, and 12-channel devices. The report includes key insights into hospital versus home-based usage, highlighting that hospitals conducted 75% of all ECG procedures in 2024.

Electrocardiograph (ECG) Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 10893.42 Million in 2026
Market Size Value By	USD 22136.77 Million by 2035
Growth Rate	CAGR of 8.2% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Monitoring ECG Systems Diagnostic ECG Systems By Application : Home-based Users Hospitals
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample